Insulin Antibodies and Insulin Autoantibodies (Q37084340)

18 August 2017

1 reference

title

Insulin antibodies and insulin autoantibodies (English)

1 reference

18 August 2017

Insulin Antibodies and Insulin Autoantibodies (English)

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

3 December 2022

1 reference

1 reference

1 reference

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

3 December 2022

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

3 December 2022

1

Greenbaum CJ

1 reference

18 August 2017

2

J. P. Palmer

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1827408

3 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1827408

3 December 2022

publication date

1 February 1991

1 reference

full work available at URL

18 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1111%2Fj.1464-5491.1991.tb01553.x

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1464-5491.1991.tb01553.x/fullpdf

3 December 2022

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

3 December 2022

1 reference

18 August 2017

8

1 reference

18 August 2017

2

1 reference

18 August 2017

97-105

1 reference

The physiologic replacement of insulin. An elusive goal

18 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.1991.TB01553.X

A method for the determination of plasma insulin antibodies and its application in normal and diabetic subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.1991.TB01553.X

Clinical significance of insulin antibodies in insulin-treated diabetic patients

21 January 2018

1

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

The immunogenicity of insulin preparation. Antibody levels before and after transfer to highly purified porcine insulin

3 December 2022

2

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Immunogenicity of highly purified bovine insulin: a comparison with conventional bovine and highly purified human insulins

3 December 2022

3

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Immunogenicity of monocomponent human and porcine insulin in newly diagnosed Type 1 (insulin-dependent) diabetic children

3 December 2022

5

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Immunogenicity of recombinant DNA human insulin

3 December 2022

6

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Transfer from purified porcine insulins to semisynthetic human insulins decreases insulin antibodies and circulating immune complexes in diabetic children and adolescents. A two-year follow-up

3 December 2022

8

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Development of insulin antibodies, metabolic control and B-cell function in newly diagnosed insulin dependent diabetic children treated with monocomponent human insulin or monocomponent porcine insulin

3 December 2022

9

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Increase in insulin antibodies during continuous subcutaneous insulin infusion and multiple-injection therapy in contrast to conventional treatment

3 December 2022

11

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Glycerol-insulin raises circulating insulin antibodies in type I diabetic patients treated with permanently implanted devices

3 December 2022

12

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Antiinsulin antibodies and clinical characteristics of patients with systemic lupus erythematosus and other connective tissue diseases with steroid induced diabetes

3 December 2022

13

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Immunologic aspects of human proinsulin therapy

3 December 2022

14

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Adverse effects of insulin antibodies on postprandial plasma glucose and insulin profiles in diabetic patients without immune insulin resistance. Implications for intensive insulin regimens.

3 December 2022

15

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Effect of insulin antibodies and their kinetic characteristics on plasma free insulin dynamics in patients with diabetes mellitus

3 December 2022

16

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Prolonged action of regular insulin in diabetic patients: lack of relationship to circulating insulin antibodies

3 December 2022

18

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Insulin, pancreatic polypeptide, and glucagon antibodies in insulin-dependent diabetes mellitus

3 December 2022

19

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Effect of anti-insulin antibodies on glycemic control in insulin treated diabetic patients

3 December 2022

20

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Importance of Timing of Preprandial Subcutaneous Insulin Administration in the Management of Diabetes Mellitus

3 December 2022

21

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Insulin-induced lipoatrophy: evidence for an immune pathogenesis

3 December 2022

22

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Insulin immunogenicity in pregnancy: maternal and fetal studies

3 December 2022

24

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Mechanism of hypoglycemia observed in a patient with insulin autoimmune syndrome

3 December 2022

27

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Spontaneous hypoglycemia and insulin autoantibodies in a patient with Graves' disease.

3 December 2022

28

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Spontaneous hypoglycemia associated with autoimmunity specific to human insulin.

3 December 2022

29

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Insulin antibodies in patients receiving penicillamine

3 December 2022

30

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

3 December 2022

Insulin antibodies

31

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Cell-mediated Immunity in Diabetes Mellitus Lymphocyte Transformation by Insulin and Insulin Fragments in Insulin-treated and Newly-diagnosed Diabetics

3 December 2022

33

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Insulin Antibodies in Insulin-Dependent Diabetics Before Insulin Treatment

3 December 2022

34

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Islet cell and insulin autoantibodies in subjects at high risk for development of type 1 (insulin-dependent) diabetes mellitus: the Lyon family study

3 December 2022

35

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Advantages and pitfalls of radioimmune and enzyme linked immunosorbent assays of insulin antibodies.

3 December 2022

36

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Systematic variation and differences in insulin-autoantibody measurements

3 December 2022

37

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

The second International Workshop on the Standardisation of Insulin Autoantibody (IAA) measurement. Held in New York, 27-30 October 1987.

3 December 2022

38

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Are insulin autoantibodies markers for insulin-dependent diabetes mellitus?

3 December 2022

41

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Relation between insulin antibody and complement-fixing islet cell antibody at clinical diagnosis of IDDM.

3 December 2022

42

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Anti-insulin antibodies in children with type I diabetes mellitus. Genetic regulation of production and presence at diagnosis before insulin replacement

3 December 2022

43

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Correlates of insulin antibodies in newly diagnosed children with insulin-dependent diabetes before insulin therapy

3 December 2022

44

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Value of insulin autoantibodies as serum markers for insulin-dependent diabetes mellitus

3 December 2022

45

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Insulin autoimmune syndrome associated with benign monoclonal gammopathy. Evidence for monoclonal insulin autoantibodies

3 December 2022

46

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Differences in epitope restriction of autoantibodies to native human insulin (IAA) and antibodies to heterologous insulin (IA).

3 December 2022

47

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Human monoclonal IgG1 insulin autoantibody from insulin autoimmune syndrome directed at determinant at asparagine site on insulin B-chain

3 December 2022

48

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Human insulin autoantibody fine specificity and H and L chain use

3 December 2022

49

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Possible target antigens in autoimmune endocrine disease

3 December 2022

50

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Virus-Induced Autoimmunity: Monoclonal Antibodies That React with Endocrine Tissues

3 December 2022

52

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Molecular mimicry between insulin and retroviral antigen p73. Development of cross-reactive autoantibodies in sera of NOD and C57BL/KsJ db/db mice.

3 December 2022

53

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Insulin antibodies in diabetic children before treatment: a marker for islet B-cell destruction?

3 December 2022

54

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Insulin autoantibodies at the clinical manifestation of type 1 (insulin-dependent) diabetes--a poor predictor of clinical course and antibody response to exogenous insulin

3 December 2022

55

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Insulin autoantibodies are associated with islet cell antibodies; their relation to insulin antibodies and B-cell function in diabetic children.

3 December 2022

56

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Relationship of insulin autoantibodies to presentation and early course of IDDM in children

3 December 2022

57

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Factors affecting insulin antibody binding in children with insulin-dependent diabetes mellitus

3 December 2022

58

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Predictive value of insulin autoantibodies for further progression of beta cell dysfunction in non-insulin-dependent diabetics

3 December 2022

59

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Islet cell antibodies and insulin autoantibodies in patients treated with oral hypoglycaemic agents.

3 December 2022

60

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Seasonality of Type 1 (insulin-dependent) diabetes mellitus: values of C-peptide, insulin antibodies and haemoglobin A1c show evidence of a more rapid loss of insulin secretion in epidemic patients

3 December 2022

61

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Relationship between serum insulin autoantibodies, islet cell antibodies and Coxsackie-B4 and mumps virus-specific antibodies at the clinical manifestation of type 1 (insulin-dependent) diabetes

3 December 2022

62

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Insulin autoantibodies in non-obese diabetic (NOD) mice and streptozotocin-induced diabetic mice

3 December 2022

63

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Natural antibodies and autoimmunity

3 December 2022

64

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Implications of anti-Ro/Sjögren's syndrome A antigen autoantibody in normal sera for autoimmunity

3 December 2022

65

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Autoantibodies to insulin are present in sera of patients with autoimmune thyroid disease

3 December 2022

66

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Islet-cell antibodies and insulin autoantibodies in association with common viral infections

3 December 2022

67

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Autoantibodies are anti-idiotype antibodies to antiviral antibodies

3 December 2022

68

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Natural autoantibodies might prevent autoimmune disease

3 December 2022

69

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Antibodies to insulin receptor followed by anti-idiotype. Antibodies to insulin in child with hypoglycemia

3 December 2022

70

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Antiinsulin receptor antibodies in an insulin-dependent diabetic may arise as autoantiidiotypes

3 December 2022

71

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Insulin and insulin-receptor autoantibodies in children with newly diagnosed IDDM before insulin therapy

3 December 2022

72

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Presence of insulin autoantibodies at clinical diagnosis of diabetes mellitus type I predicts loss of beta cell function

3 December 2022

73

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Concentration of insulin autoantibodies at onset of type I diabetes. Inverse log-linear correlation with age

3 December 2022

74

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Competitive insulin autoantibody assay. Prospective evaluation of subjects at high risk for development of type I diabetes mellitus

3 December 2022

75

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

A comparison of childhood and adult type I diabetes mellitus

3 December 2022

76

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Pre-type I diabetes. Linear loss of beta cell response to intravenous glucose.

3 December 2022

77

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Nonprogression of subclinical beta-cell dysfunction among first-degree relatives of IDDM patients. 5-yr follow-up of the Seattle Family Study

3 December 2022

78

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Predicting insulin-dependent diabetes

3 December 2022

79

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Quantification of islet-cell antibodies and prediction of insulin-dependent diabetes

3 December 2022

80

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Islet-cell antibodies as predictors of the later development of type 1 (insulin-dependent) diabetes. A study in identical twins

3 December 2022

81

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Radioassay determination of insulin autoantibodies in NOD mice. Correlation with increased risk of progression to overt diabetes

3 December 2022

83

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Insulin-dependent diabetes mellitus and autoimmunity: islet-cell autoantibodies, insulin autoantibodies, and beta-cell failure

3 December 2022

84

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Islet cell and insulin autoantibodies in organ-specific autoimmune patients. Their behaviour and predictive value for the development of type 1 (insulin-dependent) diabetes mellitus. A 10-year follow-up study

3 December 2022

85

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Prevalence of islet cell antibodies, insulin antibodies and hyperglycaemia in 2291 schoolchildren

3 December 2022

86

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Autoimmunity to insulin, beta cell dysfunction, and development of insulin-dependent diabetes mellitus

3 December 2022

87

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Insulin autoantibodies in the pre-diabetic period: correlation with islet cell antibodies and development of diabetes

3 December 2022

88

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Autoantibodies to insulin as serum markers for autoimmune insulitis

3 December 2022

90

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Ontogeny of islet cell antibodies, insulin autoantibodies and insulitis in the non-obese diabetic mouse

3 December 2022

91

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Comparison of insulin autoantibodies in diabetes-related and healthy populations by precise displacement ELISA.

3 December 2022

92

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

Life-table analysis of progression to diabetes of anti-insulin autoantibody-positive relatives of individuals with type I diabetes

3 December 2022

93

1 reference

https://api.crossref.org/works/10.1111/J.1464-5491.1991.TB01553.X

3 December 2022

Identifiers

1 reference

18 August 2017

1 reference